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Promoting palliative care in patients with motor neuron disease in TaiwanMotor neuron disease (MND) is a progressive neuro-
degenerative disease characterized by progressive weakness of
the limb, axial, bulbar, and respiratory muscles. The survival
duration for patients with MND is usually as short as 2e3
years from the onset of symptoms. Although physicians can-
not cure or halt the progression of MND, there is much that
can be done to improve patient quality of life by managing the
physical and emotional symptoms of MND.1
A previous study investigating the causes of death in 302
patients with amyotrophic lateral sclerosis, the major type of
MND, demonstrated that the most frequent cause of death was
respiratory failure.2 Therefore, the existence of dysphagia or
dyspnea is commonly understood as an indicator to commence
the palliative care plan for patients with MND. However, little
evidence is available in the published literature that identifies
the optimal approaches for patient end-of-life care in MND.3
Owing to the differences in pathogenesis and therapeutic
options of various diseases, the timetables available to discuss
end-of-life care planning for patients and their families may
vary depending on the patient’s diagnosis. In contrast to other
terminal or neurodegenerative diseases, patients with MND
usually retain sufficient mental clarity to make decisions
during the end of life stage. Astrow et al4 examined a docu-
mented discussion about the prognosis of patients with
advanced cancer and MND. They found that MND patients
were more likely than end-stage cancer patients to have a
chance to deliberate and state their intentions in wills that
address such issues as ventilation support, artificial nutrition,
and resuscitation. Therefore, physicians have the obligation to
provide adequate information to help patients make better
decisions in these challenging phases of life.
Bulbar symptoms, such as dysphagia and dysarthria, usu-
ally are signs indicating the progression to the final stage of
MND. Nutrition becomes an important issue in patient care
when dysphagia starts. Failure to maintain adequate nutritional
status is an established adverse prognostic factor in MND, and
gastrostomy is a safe and practical alternative to oral feeding.
Although there is no clear evidence that life can be extended,
evidence has shown that gastrostomy may improve the quality
of life of MND patients with bulbar symptoms.5
Respiratory muscle function is another strong predictor of
quality of life and survival in patients with MND. Respiratory
muscle weakness may cause dyspnea, nocturnal hypo-
ventilation, and sleep disruption. Respiratory failure in MND1726-4901/$ - see front matter Copyright  2013 Elsevier Taiwan LLC and the C
http://dx.doi.org/10.1016/j.jcma.2013.03.013may develop incipiently over an extended period and rarely
presents with catastrophic symptoms in an emergency sit-
uation. Therefore, patients usually can take some time to make
their choice about ventilation support. In a randomized con-
trolled trial, noninvasive ventilation (NIV) improved the sur-
vival and quality of life of MND patients without severe bulbar
dysfunction. In patients with severe bulbar impairment, NIV
still could improve sleep-related symptoms but was unlikely to
confer a substantial survival advantage.6
Although evidence has strongly supported the advantage of
using gastrostomy or NIV, the number of patients with MND
receiving these interventions varies from country to country. In
this issue of the Journal of the Chinese Medical Association,
Kang et al7 report the utilization of hospice care among
patients with MND in Taiwan. Based on the National Health
Insurance Research Database during 2005e2010, the uti-
lization of hospice care was extremely low among MND
patients in Taiwan. There were only 30 MND patients
receiving palliative care during this 5-year period.
Similar to reports in Caucasian populations, respiratory
problems were the major causes of death in Taiwanese MND
patients. However, there was no patient receiving gastrostomy,
and only 13 (23.6%) patients received NIV intervention.
According to a study conducted in the United Kingdom, there
is a 3.4-fold increase in the rate of applying NIV in MND
patients from 2000 to 2009.8 Furthermore, NIV also can be
used in home care to improve the quality of life of end-stage
MND patients.9 Therefore, there is still considerable leeway
for physicians to make an effort to promote hospice and pal-
liative care of MND patients in Taiwan.
By contrast, Kang et al noted that family physicians pro-
vided most (78.2%) of the inpatient hospice care for MND
patients in Taiwan. Specialists with different backgrounds may
cause significant variation in palliative care plans.10 Quality
communication and cooperation between working staffs with
different medical background can greatly improve the quality
of palliative care.11 It is important to assemble a multi-
disciplinary team to develop a collaborative approach in the
palliative care of MND.
Taiwan National Health Insurance has, for many years,
approved MND for hospice care payment; however, very few
MND patients utilize this service in Taiwan. Consequently,
physicians involved in palliative care shouldmake a greater effort
to promote the quality of end-of-life care for MND patients.hinese Medical Association. All rights reserved.
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